Development of two different formats of heterogeneous fluorescence immunoassay for bioanalysis of afatinib by employing fluorescence plate reader and KinExA 3200 immunosensor

Afatinib (AFT) is a potent and highly selective drug used to treat various solid tumors including non-small cell lung cancer (NSCLC). To ensure safe and effective treatment of cancer patients with AFT, its plasma concentrations should be monitored. Thus, sensitive immunoassays are required for measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Ibrahim A., AlRabiah, Haitham, Hamidaddin, Mohammed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791937/
https://www.ncbi.nlm.nih.gov/pubmed/31611565
http://dx.doi.org/10.1038/s41598-019-51288-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791937/
https://www.ncbi.nlm.nih.gov/pubmed/31611565
http://dx.doi.org/10.1038/s41598-019-51288-5

Ejemplares similares